Compare GSK plc (GSK) vs Direxion Daily 20 Year Treasury Bull 3X Shares (TMF) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
GSK plc vs Direxion Daily 20 Year Treasury Bull 3X Shares — how do they compare? GSK plc trades at $51.85 (market cap $101.34B), while Direxion Daily 20 Year Treasury Bull 3X Shares trades at $32.66. The key difference: GSK plc pays a 3.49% dividend while Direxion Daily 20 Year Treasury Bull 3X Shares pays none, and GSK plc is trading nearer its 52-week high, Direxion Daily 20 Year Treasury Bull 3X Shares nearer its low. Which is the better fit depends on your goals.
| GSK | TMF | |
|---|---|---|
Market Cap | $101.34B | — |
Sector | Health | Leveraged / Inverse |
52-Week High | $61.18 | $44.14 |
52-Week Low | $36.20 | $31.85 |
Enterprise Value | $121.95B | — |
Dividend Yield | 3.49% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About GSK plc
In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, cancer, and antiviral, as well as vaccines. GSK uses joint ventures to gain additional scale in certain markets like HIV.
Read more on GSK →About Direxion Daily 20 Year Treasury Bull 3X Shares
TMF is a leveraged ETF that seeks to provide 300% (3x) of the daily performance of the ICE U.S. Treasury 20+ Year Bond Index. It is a tactical instrument used by sophisticated traders to capitalize on declining interest rates or to hedge against equity market volatility. Due to its daily reset mechanism and high expense ratio, TMF is structurally designed for short-term speculation rather than long-term buy-and-hold investing.
Read more on TMF →
